Explore the Efficacy and Safety of Pembrolizumab and RC48-ADC in HER2 expressing Metastatic Colorectal cancer Failed at Least two Lines of Systemic Treatment
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/41839
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: 1:pembrolizumab plus disitamab vedotin
Primary outcome(s): Objective Response Rate
Study Design: Single arm
创建时间：
2022-09-15
